Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 2
1991 2
1994 1
1996 2
1997 1
1998 2
1999 1
2000 5
2001 4
2002 4
2003 4
2004 2
2005 5
2006 2
2007 4
2008 7
2009 10
2010 6
2011 6
2012 6
2013 17
2014 1
2015 3
2016 6
2017 6
2018 9
2019 5
2020 8
2021 7
2022 7
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells.
Khatri B, Tessneer KL, Rasmussen A, Aghakhanian F, Reksten TR, Adler A, Alevizos I, Anaya JM, Aqrawi LA, Baecklund E, Brun JG, Bucher SM, Eloranta ML, Engelke F, Forsblad-d'Elia H, Glenn SB, Hammenfors D, Imgenberg-Kreuz J, Jensen JL, Johnsen SJA, Jonsson MV, Kvarnström M, Kelly JA, Li H, Mandl T, Martín J, Nocturne G, Norheim KB, Palm Ø, Skarstein K, Stolarczyk AM, Taylor KE, Teruel M, Theander E, Venuturupalli S, Wallace DJ, Grundahl KM, Hefner KS, Radfar L, Lewis DM, Stone DU, Kaufman CE, Brennan MT, Guthridge JM, James JA, Scofield RH, Gaffney PM, Criswell LA, Jonsson R, Eriksson P, Bowman SJ, Omdal R, Rönnblom L, Warner B, Rischmueller M, Witte T, Farris AD, Mariette X, Alarcon-Riquelme ME; PRECISESADS Clinical Consortium; Shiboski CH; Sjögren’s International Collaborative Clinical Alliance (SICCA); Wahren-Herlenius M, Ng WF; UK Primary Sjögren’s Syndrome Registry; Sivils KL, Adrianto I, Nordmark G, Lessard CJ. Khatri B, et al. Among authors: eloranta ml. Nat Commun. 2022 Jul 27;13(1):4287. doi: 10.1038/s41467-022-30773-y. Nat Commun. 2022. PMID: 35896530 Free PMC article.
B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus.
Hedenstedt A, Reid S, Sayadi A, Eloranta ML, Skoglund E, Bolin K, Frodlund M, Lerang K, Jönsen A, Rantapää-Dahlqvist S, Bengtsson AA, Rudin A, Molberg Ø, Sjöwall C, Sandling JK, Leonard D. Hedenstedt A, et al. Among authors: eloranta ml. Lupus Sci Med. 2023 Oct;10(2):e000926. doi: 10.1136/lupus-2023-000926. Lupus Sci Med. 2023. PMID: 37844960 Free PMC article.
Type I interferon and lupus.
Rönnblom L, Alm GV, Eloranta ML. Rönnblom L, et al. Among authors: eloranta ml. Curr Opin Rheumatol. 2009 Sep;21(5):471-7. doi: 10.1097/BOR.0b013e32832e089e. Curr Opin Rheumatol. 2009. PMID: 19525849 Review.
The interferon signature in autoimmune diseases.
Rönnblom L, Eloranta ML. Rönnblom L, et al. Among authors: eloranta ml. Curr Opin Rheumatol. 2013 Mar;25(2):248-53. doi: 10.1097/BOR.0b013e32835c7e32. Curr Opin Rheumatol. 2013. PMID: 23249830 Review.
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.
Rodríguez-Carrio J, Burska A, Conaghan PG, Dik WA, Biesen R, Eloranta ML, Cavalli G, Visser M, Boumpas DT, Bertsias G, Wahren-Herlenius M, Rehwinkel J, Frémond ML, Crow MK, Ronnblom L, Vital E, Versnel M. Rodríguez-Carrio J, et al. Among authors: eloranta ml. RMD Open. 2023 Mar;9(1):e002864. doi: 10.1136/rmdopen-2022-002864. RMD Open. 2023. PMID: 36882218 Free PMC article.
The type I interferon system in the development of lupus.
Rönnblom L, Alm GV, Eloranta ML. Rönnblom L, et al. Among authors: eloranta ml. Semin Immunol. 2011 Apr;23(2):113-21. doi: 10.1016/j.smim.2011.01.009. Epub 2011 Feb 2. Semin Immunol. 2011. PMID: 21292501 Review.
The type I interferon system in systemic lupus erythematosus.
Rönnblom L, Eloranta ML, Alm GV. Rönnblom L, et al. Among authors: eloranta ml. Arthritis Rheum. 2006 Feb;54(2):408-20. doi: 10.1002/art.21571. Arthritis Rheum. 2006. PMID: 16447217 Free article. Review. No abstract available.
Primary Sjögren's syndrome and the type I interferon system.
Nordmark G, Eloranta ML, Ronnblom L. Nordmark G, et al. Among authors: eloranta ml. Curr Pharm Biotechnol. 2012 Aug;13(10):2054-62. doi: 10.2174/138920112802273290. Curr Pharm Biotechnol. 2012. PMID: 22208657 Review.
136 results